[{"Assets_0_Q2_USD":150980000.0,"CommonStockSharesOutstanding_0_Q2_shares":13488738.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-3938000.0,"NetIncomeLoss_1_Q2_USD":1262000.0,"NetIncomeLoss_2_Q2_USD":2572000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":13390000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":13379000.0,"StockholdersEquity_0_Q2_USD":115313000.0,"EarningsPerShareBasic_1_Q2_USD":0.09,"EarningsPerShareBasic_2_Q2_USD":0.19,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20190503"}]